Investing.com -- Coinbase shares may face near-term pressure according to Monness, Crespi, Hardt analysts. The firm downgraded the stock to Neutral from Buy and removed its price target in a note on Tuesday, citing expectations for a weaker-than-anticipated first quarter and a disappointing Q2 outlook. Advertisement: High Yield Savings Offers Earn up to 4.35% APY** with $5k balance View Offer Earn up to 4.00% APY with Savings Pods View Offer Earn up to 3.80% APY¹ & up to $300 Cash Bonus with Direct Deposit View Offer Powered by Money.com - Yahoo may earn commission from the links above. “We downgrade to Neutral… on concern 1Q25 likely to be light,” analysts wrote in a note, also removing their price target. They attributed the call to “tepid QTD txn revenue results” and said the move is “tactical around print as we expect a miss/estimate revision down.” Monness estimates transaction revenue fell roughly 12% quarter-over-quarter, exacerbated by a rising mix of lower-fee stablecoin trades. They warned that “subscription + services ETH price drag doesn’t seem to be fully appreciated by consensus.” Coinbase’s market share is said to remain a bright spot. “Share of volumes looks remarkably healthy,” analysts wrote, noting that trading declines in March and April were “more muted than market.” The firm also flagged new risks from Washington, specifically delays to the GENIUS Act, a proposed stablecoin regulatory framework. The bill “hit some snags over the weekend” after nine Democratic senators withdrew support, citing concerns over anti-money laundering provisions and regulatory oversight. This leaves “an air gap to the 60 votes needed” to advance the legislation, says the firm. Monness believes the current version of the bill could create “heightened regulatory complexity,” with fragmented oversight and compliance challenges that may limit industry scalability. By contrast, they state that the STABLE Act, which requires federal supervision and a bank license, “quite possibly ends up as a net benefit to Coinbase (NASDAQ:COIN),” given its compliance-forward posture. Despite the downgrade, the firm remains positive on Coinbase in the long term, citing “TAM expansion and real-world utility” and improving profitability. “Economics of this business over time are more likely than not to continue improving as a matter of scale,” they wrote. Related articles Coinbase downgraded as Q1 ’likely to be light’ says Monness, Crespi, Hardt Trump hints at major positive announcement ahead of Middle East trip Paul Tudor Jones predicts new stock market lows despite potential tariff reduction View Comments
Coinbase downgraded as Q1 ’likely to be light’ says Monness, Crespi, Hardt
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...